Health, Fitness,Dite plan, health tips,athletic club,crunch fitness,fitness studio,lose weight,fitness world,mens health,aerobic,personal trainer,lifetime fitness,nutrition,workout,fitness first,weight loss,how to lose weight,exercise,24 hour fitness,

09/30/20
Twitter Facebook

12:48 ,
Rapeseed has the potential to replace soy as the best plant-based source of protein for humans. In a current study, nutrition scientists found that rapeseed protein consumption has comparable beneficial effects on human metabolism as soy protein. The glucose metabolism and satiety were even better. Another advantage: The proteins can be obtained from the by-products of rapeseed oil production.

from Top Health News -- ScienceDaily https://ift.tt/3cIMSKw
Twitter Facebook

12:48 ,
Scientists have made a leap forward in our understanding of how COVID-19 infections trigger deadly levels of lung inflammation. Their discovery of a pathway that sets the lungs ablaze with inflammation has launched a search for new therapeutics that could block this process before it can take off and turn fatal.

from Top Health News -- ScienceDaily https://ift.tt/3n5Wt36
Twitter Facebook

12:48 ,
Researchers studying interferons, immune response proteins released naturally by human cells when viruses are detected, have uncovered new details on the mechanisms underlying cell defenses. They describe the intricate, time-dependent regulatory mechanisms that human cells use to control the duration and strength of antiviral responses triggered by interferon. Based on these findings, researchers are now able to design time-dependent administrations of interferon to minimize inhibitory factors and boost therapeutic responses.

from Top Health News -- ScienceDaily https://ift.tt/30lZGBK
Twitter Facebook

12:25 , , , ,

Food labels contain a wealth of information: calories, serving size, and the amounts of fat, sugar, vitamins, and fiber contained in a food, among other things. But do consumers know how to effectively use this information? A recent study showed that some consumers are struggling, especially when it comes to understanding whole grains.

Recent study highlights consumer confusion

For the study, published in Public Health Nutrition, researchers conducted two experiments to examine consumer understanding of whole grains on food labels. The research, which focused on food labels on bread, cereal, and crackers, was done online and involved more than 1,000 adults.

In the first experiment, researchers displayed pairs of products with different amounts of whole grains (based on the ingredients list and fiber content), sugar, and salt on mocked-up Nutrition Facts panels. One of the products contained a good amount of whole grains but made no claims on the front of the package. The other product had less overall whole grains, but sold itself with terms like “multigrain” or “wheat” on the front of the package. Results showed that 29% to 47% of study participants incorrectly identified the less healthy product as the better option.

The second experiment used actual food labels and asked the study participants to identify which products had 100% whole grain, mostly whole grain, or little to no whole grain. About half of the study participants (43% to 51%) overstated the amount of whole grains in the products that were mostly refined grains. For another product, composed mainly of whole grains, 17% of the consumers understated the whole grain content.

The study concluded that consumers have difficulty identifying the healthfulness and the whole-grain content of some packaged foods, and that they rely on whole-grain labeling on the front of the package rather than considering information from the Nutrition Facts label and the ingredients list.

Why should we eat whole grains?

Whole grains refer to the entire grain kernel, including the bran, germ, and endosperm. The process of refining grains removes most of the bran and germ, leaving the endosperm (white flour). Each component of the whole grain contributes different nutrients, including vitamins, minerals, fiber, and other health-promoting compounds.

Whole grains offer a complete package of health benefits, unlike refined grains, which are stripped of valuable nutrients in the refining process. Studies show that they decrease our risk for several chronic diseases including type 2 diabetes, heart disease, stroke, and death from any cause.

Whole grains are also a rich source of vitamins and minerals. Compared to enriched white flour, 100% whole wheat flour contains: 96% more vitamin E, 82% more vitamin B6, 80% more selenium, 78% more magnesium, 72% more chromium, 58% more copper, 52% more zinc, and 37% more folate.

Hulled barley, bulgur, whole-grain couscous, oats, rye, spelt, triticale, and whole wheat are all whole grains. Gluten-free whole grains include amaranth, brown rice, buckwheat, corn, millet, quinoa, teff, and wild rice.

Tips for selecting whole grain products

Don’t rely on front-of-the-package marketing. Just because the package shows a photo of a beautiful wheat field does not necessarily mean its contents are made with a whole grain. Even packages that say “multigrain,” “wheat,” “double fiber,” “cracked wheat,” “7 grain,” “stone ground,” “enriched,” “fortified,” or “made with whole grains” may be mostly enriched white flour.

Do not assume that darker is better. Products that are darker in color are not necessarily whole grains. Ingredients such as molasses or caramel coloring may have been used to impart color.

Check the ingredients list. The relative amount of whole grain in the food can be gauged by the placement of the grain in the ingredients list. The whole grain should be the first ingredient — or the second ingredient, after water. For foods with multiple whole-grain ingredients, they should appear near the beginning of the ingredients list. Choose foods that list “whole” or “whole grain” before the grain’s name, such as whole rye flour, whole wheat flour, or whole buckwheat.

Know what the labels really mean

If the label says… The product contains…
100% whole grain No refined flour
Made with whole grains May contain a little or a lot of whole grains
Whole grain As little as 51% whole grain flour
Good source of whole grain 15% to 25% whole grain
Multigrain A mixture of grains, possibly all or mostly refined grains

Look at the Nutrition Facts label

The amount of fiber listed on the food label can provide a helpful clue to a food’s whole grain content. When selecting a product, choose breads that contain at least 3 grams of fiber per serving, cereals that have at least 5 grams of fiber per serving, and crackers that contain at least 3 grams of fiber per serving.

But don’t focus solely on whole grains. When trying to improve your diet, use food labels to guide you toward products with less sodium, saturated fat, and added sugar as well.

The post Whole grains or no grains? Food labels can be misleading appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/33j5oGx
Twitter Facebook

09:48 ,
In a study recently published in BMC Public Health, Arizona State University researchers found that heavy users of screens -- defined as those who use screens an average of 17.5 hours per day -- reported the least healthful dietary patterns and the poorest health-related characteristics compared with moderate and light users, who averaged roughly 11.3 and 7 hours of screen use per day, respectively.

from Top Health News -- ScienceDaily https://ift.tt/36lQpx9
Twitter Facebook

09:48 ,
Neuronal communication is so fast, and at such a small scale, that it is exceedingly difficult to explain precisely how it occurs. An observation enabled by a custom imaging system, has led to a clear understanding of how neurons communicate with each other by modulating the 'tone' of their signal, which previously had eluded the field.

from Top Health News -- ScienceDaily https://ift.tt/2Gl2Caz
Twitter Facebook

09:48 ,
Researchers shed new light on how Zika virus hijacks our own cellular machinery to break down an essential protein for neurological development, getting it to 'eat itself'. By triggering this process known as autophagy, Zika virus is able to degrade an important protein, a process that may contribute to the development of neurological or brain deficiencies and congenital birth defects in the newborns of infected pregnant women.

from Top Health News -- ScienceDaily https://ift.tt/30jeBMQ
Twitter Facebook

00:22 , ,

Children’s Health Defense (CHD), founded by Robert F. Kennedy Jr., created “The Jab” video above, which highlights the gold rush that occurred for pharmaceutical companies when the World Health Organization declared swine flu a pandemic in 2009. While Big Pharma got richer, an experimental vaccine was hastily rushed to market, and thousands suffered adverse effects as a result.

Now, in the midst of another controversial pandemic, we’re facing an eerily similar playbook — with pharmaceutical companies eager to cash in on the first COVID-19 vaccine, begging the question, “Are we are being played — again?”1

Pandemic Playbook: First, ‘The Trap’

Pandemics have been coming and going around the globe for centuries, but in recent history they’ve been used as points of manipulation that have profited corporations, particularly pharmaceutical companies. In 2005, you may remember, the bird flu epidemic was predicted to kill from 2 million to 150 million people,2 but turned out to be a whole lot of hot air, and prompted me to write the book “The Great Bird Flu Hoax.”

At the time, Nature Immunology published an editorial stating that the fear of bird flu had prompted government officials to prioritize developing plans to deal with pandemic influenza, and the WHO had named bird flu as the No. 1 health concern.

“This heightened concern exists despite any evidence suggesting sustained human-to-human transmission of the potentially pandemic H5N1 strain of avian influenza virus,” according to the article.3 In the years that followed, WHO executed agreements — so called “sleeping contracts” — with European and African nations in the name of protecting people from a future global pandemic.

The contracts stated that countries would buy vaccines in the event of a pandemic, but this would only be necessary if WHO declared a Phase 6 influenza pandemic.4 Both GlaxoSmithKline (GSK) and Baxter were named in contracts with the U.K. parliament, for instance, which stated the pharmaceutical companies would supply a pandemic influenza vaccine to the U.K. and were valued at £155.4 million (more than $206 million) over four years.5

“Unfortunately,” CHD noted, “the government officials who signed the contracts never suspected that GSK makes multimillion-dollar donations to the WHO in return for control over decisions that result in GSK windfalls.”6

WHO Changes Definition of Pandemic

It was June 11, 2009, when WHO declared H1N1 swine flu to be a Phase 6 global influenza pandemic, even though it had only caused 144 deaths worldwide. That declaration put the sleeping contracts into an active state, to the tune of $18 billion directed to the production of H1N1 vaccines, including GSK’s Pandemrix.

Prior to the pandemic’s declaration, WHO had defined a pandemic at the top of their Pandemic Preparedness website as follows:7

“An influenza pandemic occurs when a new influenza virus appears against which the human population has no immunity, resulting in several, simultaneous epidemics worldwide with enormous numbers of deaths and illness.”

The 144-person death toll certainly didn’t seem to fit the description of an “enormous” number of deaths, but, conveniently, it didn’t matter because WHO changed their definition of a pandemic. According to CHD in “The Jab”:8

“Suspiciously, just 39 days before declaring the pandemic, the W.H.O. deleted the pandemic definition from their website. When confronted, they told the media that their definition ‘painted a rather bleak picture and could be very scary.’

In the new definition, the W.H.O. no longer required that anyone die before they declare a pandemic. GSK’s Pandemrix jab was an experimental vaccine that was never tested for safety or efficacy. It was given straight to hundreds of millions of Africans and Europeans. This wasn’t the time for red tape and formalities. By any definition — rather, by the new definition, we were in a global pandemic.”

Pandemic Expert Panel Fraught With Conflicts of Interest

Lest anyone suggest that WHO, which received funding from GSK, wasn’t entirely unbiased in their decision to declare swine flu a pandemic, it should be noted that the opinion of an Emergency Committee from WHO’s International Health Regulations Review Committee was sought.

The guidance of many of these leading experts benefited the pharmaceutical industry, but their identities were kept secret in order to “protect them from outside influences.”9 In 2010, however, a joint investigation by the BMJ and the Bureau of Investigative Journalism revealed troubling conflicts of interest between key panel members and the pharmaceutical industry. According to the BMJ:10

“The investigation by the BMJ/The Bureau reveals a system struggling to manage the inherent conflict between the pharmaceutical industry, WHO, and the global public health system, which all draw on the same pool of scientific experts.

Our investigation has identified key scientists involved in WHO pandemic planning who had declarable interests, some of whom are or have been funded by pharmaceutical firms that stood to gain from the guidance they were drafting.

Yet these interests have never been publicly disclosed by WHO and, despite repeated requests from the BMJ/The Bureau, WHO has failed to provide any details about whether such conflicts were declared by the relevant experts and what, if anything, was done about them.”

H1N1 Swine Flu Vaccine Caused Narcolepsy

As is the case with all vaccines, unexpected injuries can occur, but in the case of the ASO3-adjuvanted swine flu vaccine Pandemrix, GSK continued to promote the vaccine even as cases of adverse events rose. Pandemrix was released in Europe during the swine flu pandemic of 2009 to 2010. Its approval process was accelerated, with most safety and efficacy tests bypassed.

At the time, the WHO tried to assure the public that this was safe, but at the same time they admitted, “Further testing of safety and effectiveness will need to take place after administration of the vaccine has begun.”11

Years later, Pandemrix (used in Europe but not in the U.S. during 2009-2010) was causally linked to childhood narcolepsy,12 a chronic neurologic condition in which your brain loses its ability to regulate sleep-wake cycles normally.

As a result, this causes you to suddenly fall into a deep sleep at any point during the day, which is debilitating and seriously affects quality of life. Many cases of narcolepsy also involve cataplexy, which is the sudden loss of voluntary muscle control triggered by strong emotions or laughter. According to “The Jab”:13

“GSK’s adjuvanted Pandemrix vaccine caused both [narcolepsy and cataplexy], devastating at least 1,300 children across Europe — for life. In the media, GSK’s AS03 adjuvant, added to stimulate a powerful immune response, shouldered the blame for amplifying these heinous reactions.

Documents obtained by plaintiffs in a series of European lawsuits revealed that GSK knew about the mounting adverse events associated with Pandemrix in the winter of 2009 — including a 5.4-fold increase in death. By December 2009, an injured person filed a report with GSK for every 12,500 doses of Pandemrix administered. Yet, they continued promoting their vaccine in order to move inventory.”

Later, in 2019, researchers described a “novel association between Pandemrix-associated narcolepsy and the non-coding RNA gene GDNF-AS1”14 — a gene thought to regulate the production of glial cell line-derived neurotrophic factor or GDNF, a protein that plays an important role in neuronal survival.

According to the researchers, “Changes in regulation of GDNF have been associated with neurodegenerative diseases. This finding may increase the understanding of disease mechanisms underlying narcolepsy.”15

Antiviral Drugs Also Fraudulently Stockpiled for Pandemics

Pandemrix is only one example of a pandemic medication gone wrong. Antiviral drugs like Tamiflu are another, yet are still recommended by government agencies like the U.S. CDC,16 despite long-standing studies questioning their effectiveness and safety.

At one point, WHO even classified Tamiflu as an "essential" medicine and recommended that it be used “as soon as possible” after a flu diagnosis.17 WHO’s definition of “essential” is reserved for drugs "selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness."18

That status was downgraded in 2017, when the WHO moved Tamiflu from a “core” essential medicine to a “complementary” drug, which is used for those that are less cost effective.19

In a BMJ editorial, Mark Ebell, professor of epidemiology at the University of Georgia, called the move “far too late” and described a multisystem failure that allowed Tamiflu to become a blockbuster medication,20 once again in the name of potential pandemics:21

“Concerned about a possible outbreak of avian influenza, as well as the H1N1 pandemic in 2009, the UK government stockpiled oseltamivir at a cost of over £600m (€680m; $770m) from 2006 to 2014. Similarly, the US government has spent over $1.5bn stockpiling the drug, based on recommendations from the Centers for Disease Control and Prevention (CDC).”

In 2019, a whistleblower lawsuit was filed against Tamiflu’s maker, Roche, alleging Roche duped the U.S. government into stockpiling Tamiflu while mispresenting its effectiveness. According to the suit, Roche knew Tamiflu was ineffective at fighting influenza pandemics but went ahead and “masterfully marketed this drug to fill Roche’s coffers at taxpayer expense.”22

COVID-19 Deja-Vu

The unsettling question now, amid the COVID-19 pandemic, is whether another experimental vaccine will make it to market, padding the drug companies’ pockets further while putting lives at risk. Asking, “Will they get away with it this time?” “The Jab” notes:23

“Relying on the same attenuated definition of ‘pandemic,’ on March 11, 2020, the World Health Organization declared COVID-19 to be a global pandemic when its partner, the COVID-19 Therapeutics Accelerator, received 125 million-dollar commitments from the Gates Foundation and Mastercard just one day prior.

On July 31, 2020, GSK and Sanofi scored 2.1 billion US taxpayer dollars to partner on an experimental Covid-19 vaccine. Sanofi will provide the vaccine and GSK will provide — you guessed it — hundreds of millions of doses of their AS03 adjuvant from the 2009 narcolepsy epidemic.”

The earliest results from COVID-19 vaccine studies are starting to roll in, and they’re far from reassuring. Initially, public health officials had stated that a vaccine could be ready in an unprecedented 12 to 18 months. Now, there’s talk of accelerating vaccine delivery even further, with a target date of fall 2020.24

However, as noted by Barbara Loe Fisher, co-founder of the National Vaccine Information Center (NVIC), based on the historical failures of past coronavirus vaccines, a fast-tracked COVID-19 vaccine could become one of the biggest public health disasters in history.

And, no one involved is accountable or will face any repercussions, just as GSK was not held accountable for the narcolepsy cases caused by Pandemrix. Instead, they will all continue to profit.



from Articles https://ift.tt/3cImWyC
via IFTTT
Twitter Facebook

00:22 , ,

Earlier this year, I reported that carcinogenic N-nitrosodimethylamine (NDMA) had been found in certain blood pressure, heartburn and diabetes medications. As of February 2020, drugs recalled due to contamination with this poison included:1

  • Valsartan, losartan and irbesartan (high blood pressure medications)
  • Zantac2 and Axid (heartburn medications)
  • Metformin (diabetes medication)

In the case of valsartan, the three companies whose drugs were recalled in 2018 had all purchased the active ingredient from a Chinese company called Zhejiang Huahai Pharmaceutical Co. It’s one of China’s largest manufacturers of generics.3

Since 2018, the recall has been expanded dozens of times to also include losartan and irbesartan, made by more than 10 different companies with distribution in some 30 countries.4

As reported5 by Bloomberg in December 2019, the U.S. Food and Drug Administration checks less than 1% of imported drugs for impurities (or potency for that matter). Clearly, the regulatory system, which is meant to safeguard patients, is broken, and trust in drug manufacturers is often misplaced.

Disturbingly, Bloomberg’s report6 suggests the NDMA contamination at Huahai may have been intentional, at least in the sense that profitability was prioritized over thorough quality testing and perfecting of novel manufacturing methods.

What Is NDMA?

NDMA is a water-soluble chemical known to cause cancer in animals. In humans, it’s classified7 as a probable carcinogen and causes serious liver damage and liver failure.8

According to the Environmental Protection Agency’s technical fact sheet,9 NDMA, which can form in both industrial and natural chemical processes, is a member of N-ni-trosamines, a family of potent carcinogens.

“Potential industrial sources include byproducts from tanneries, pesticide manufacturing plants, rubber and tire manufacturers, alkylamine manufacture and use sites, fish processing facilities, foundries and dye manufacturers,” the EPA notes. However, we now know the chemical can also be produced during the manufacturing of drugs.

Historically, there are several cases10 in which NDMA was used as a poison. In 1978, a German teacher's wife died after he put NDMA in her jam and a Nebraska man was sentenced to death that same year for spiking lemonade with it, killing two people.

In 2013, a Chinese medical student died as a result of an April Fool's prank when NDMA was put into the water cooler, and in 2018, a Canadian graduate student poisoned a post-doctoral fellow by injecting it into an apple pie. Meanwhile, hundreds of millions of patients around the world have been taking drugs contaminated with this poison, oftentimes daily, for years on end.

Can FDA Ensure Drug Safety?

Bloomberg’s report11 reviews the history of how carcinogens like NDMA have crept into the generic drug supply, and raises serious questions about the FDA’s ability to ensure drug safety.

The article features the story of Karen Brackman, who after taking generic valsartan for two years suddenly found herself with a diagnosis of a rare and aggressive liver cancer, despite having no family history of cancer, and no specific risk factors for it.

As reported by Bloomberg,12 some of the contaminated valsartan pills contained as much as 17 micrograms of NDMA per pill, an amount estimated by European health regulators to give 1 in 3,390 people cancer. Brackman suspects she’s one of the unlucky ones.

While generics are a boon to patients in that they’re far less expensive while still providing the same benefits, there’s more room for error as they also receive far less scrutiny by regulators, and manufacturers are trusted to regulate themselves.

Most Active Ingredients Are Manufactured in China and India

An estimated 80% of all active drug ingredients are manufactured in China and India, and overseas plants are rarely inspected by U.S. authorities. At present, the U.S. has just one FDA inspector’s office in China. In the case of valsartan, even when a plant is inspected and found wanting, it can take years before problems are addressed — if ever.

“Huahai, the first manufacturer found to have NDMA in its valsartan, is also the one whose product had the highest concentration,” Bloomberg reports.13

”When an FDA inspector visited in May 2017, he was alarmed by what he saw: aging, rusty machinery; customer complaints dismissed without reason; testing anomalies that were never looked into.

He reported that the company was ignoring signs its products were contaminated. Senior FDA officials didn’t reprimand Huahai; they expected the company to resolve the problem on its own. Huahai didn’t …

It wasn’t until a year later that another company … found an impurity in Huahai’s valsartan and identified it as NDMA. That was when the FDA demanded drugmakers begin looking for NDMA in their valsartan. They found it again and again.”

As David Gortler, a drug safety consultant and former FDA medical officer, told Bloomberg, “Valsartan is just the one we caught. Who knows how many more [tainted drugs] are out there?” Well, we now know the NDMA contamination affects many other drugs as well, including metformin, used by more than 78.6 million Americans as of 2017.14

Huahai’s Mistake

Bloomberg goes on to recount some of the historical details of Huahei, from its inception in 1989 to its current status as one of the largest generic’s companies in China, and the first Chinese company to gain FDA approval to export finished drugs to the U.S. — a generic HIV medication.

When Novartis’ patent on Diovan (the brand name for its valsartan drug) expired in 2011, Huahai became one of the companies to manufacture valsartan for generic drug companies. Valsartan, being a simple compound to make and used daily by millions, looked like it could be just what Huahai needed to grow and improve its bottom line.

Now, as explained by Bloomberg, if a company like Huahai wants to create its own version of a generic drug and then export it to the U.S., they must first get FDA approval. However, if they’re just manufacturing and supplying the active ingredient to a U.S. company that then produces the finished product, then FDA approval is not required. All they have to do is inform the FDA if there are any changes to the manufacturing process.

In the case of Huahai’s valsartan, the company did make a change to its manufacturing process, but downplayed its significance. In November 2011, Huahai stopped using the solvent used by Novartis in the manufacturing of the brand name drug, and started using another called dimethylformamide (DMF).

This turns out to have been a massive mistake, as side reactions ended up producing NDMA, which could not be removed from the drug. “The chemists at Huahai either didn’t realize that or didn’t consider it a potential hazard,” Bloomberg writes, adding that, in 2018, after the recall began, vice chairman of Huahai, Jun Du, told an FDA inspector that “The purpose of the change was to save money,” thus increasing their profits.

The cost-savings were so substantial, it allowed Huahai to dominate the global market share for valsartan. Making matters worse, since Huahai’s patent was public, other generic companies copied the new, toxic, process. According to Bloomberg,15 this is “one reason so much of the world’s valsartan supply is now contaminated.”

Incompetence or Intentional Poisoning?

It’s hard to justify a defense of ignorance, though, seeing how the 2017 FDA inspector’s report noted multiple problems at the plant, including suspicious contaminants showing up in quality tests.

Du claimed the tests showed “ghost peaks … from time to time for undetermined reasons.” In another instance, he referred to the residual spike showing in testing as “noise.” Huahai never investigated to determine what the contaminants might be, or how they got there. Instead, they simply omitted the incriminating tests from official reports.

The FDA inspector recommended the agency issue a warning letter, which would have meant Huahai would have to pass another inspection before continuing its manufacturing. But the FDA didn’t send a warning letter. Instead, they urged Huahai to resolve the issues on their own — which they didn’t.

Disturbingly, a lax FDA approach to inspections that reveal faked quality testing is not unusual. Bloomberg spoke to Michael de la Torre, who runs a database of FDA inspections. According to Torre, in the five years up to 2019, the FDA issued warning letters in response to faked data just 25% of the time.

Bloomberg also recounts a number of quality problems discovered at Indian drug manufacturing plants. Clearly, FDA is failing in its mission to regulate the generics industry overseas.

The industry is expected to regulate itself, and profit wins over quality concerns most of the time when no one is around to hold the companies accountable. A company is only as ethical and conscientious as the people running it.

Quality problems are really not uncommon. The New Haven, Connecticut-based online pharmacy Valisure LLC tests every drug it orders, and reports rejecting more than 10% of all batches it receives — in some cases due to inaccurate amounts of active ingredient, in others due to contaminants or other inconsistencies in quality.16

Kevin Schug, analytical chemistry professor at the University of Texas, told Bloomberg17 Huahai “certainly should have caught” the NMDA contamination, and “should have modified the procedure to correct it.” Former FDA medical officer Gortler agreed, saying, “Any well-trained analytical chemist would know to check. If it’s not intentional, it’s incompetence. At some point, those are the same.”

Valisure CEO David Light told Bloomberg that while people in the industry are well aware of the problems, the overwhelming consensus is that it’s not “their” problem. “There’s no liability at any one point,” he said. “The only element who cares in this whole global supply chain is patients.”

The FDA didn’t send a warning letter18 to Huahai until November 2018, stating the obvious: The company should have anticipated the possibility that changing the process to use DMF solvent might cause problems, and when testing revealed anomalies, they should have identified the impurity.

Brackman filed a lawsuit against Huahai in April 2019. About 140 others have also sued Huahai and other drugmakers involved in the valsartan recall, and lawyers are reviewing several hundred additional cases, Bloomberg reports.

Bottom Line

This devastating and pervasive toxic exposure results largely from people’s reliance on using drugs as symptomatic bandages that in no way, shape or form treat the cause of the disease. They trust their physicians to help them but sadly they have been captured by the drug industry and are nearly universally clueless on how to identify and address the underlying cause of most diseases.

That is why it is crucial to understand that YOU are responsible for your own health and need to use physicians as your consultants, and not implicitly trust them. If you provide your body with what it needs, it typically tends to self-correct and get better so you can avoid these dangerous medications which, rarely, if ever, resolve the foundational cause.

Fortunately, this COVID-19 crisis has shown us the two most important physical strategies to optimize your health: vitamin D and metabolic flexibility. The ability to eliminate insulin resistance is a strategy that addresses the majority of illnesses that you will ever encounter in your lifetime.

This is why time-restricted eating, eliminating industrially processed seed oils like soy, corn and canola oils, eating a cyclical ketogenic diet, exercising and sleeping well can improve, if not eliminate, most conditions that you would need to take medications for. As you can see, drugs can harm you just because they were made with shortcuts to increase company profits.

When you follow these health principles you will decrease, if not eliminate, your need for these dangerous medications. You will also enjoy a high degree of health and freedom from the pain, disability and suffering associated with these conditions.



from Articles https://ift.tt/34hk746
via IFTTT

MKRdezign

Contact Form

Name

Email *

Message *

Powered by Blogger.
Javascript DisablePlease Enable Javascript To See All Widget